29 November 2017 - Deborah Wilkes
Archived
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has switched Pfizer’s erectile-dysfunction drug Viagra (sildenafil) from prescription to non-prescription status following a public consultation. Pfizer said it was “working on plans for the launch of Viagra Connect in the UK in the spring of 2018”.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.